Covid-19 Impact on Femtosecond Ophthalmic Lasers Market Research Report, 2020-2025

A recent report on Femtosecond Ophthalmic Lasers Market provides a detailed analysis of the industry size, revenue forecasts and geographical landscape pertaining to this business space. Additionally, the report highlights primary obstacles and the latest growth trends accepted by key players that form a part of the competitive spectrum of this business.

"Femtosecond Ophthalmic Lasers Market is valued at USD 1278.00 Million in 2018 and expected to reach USD 1774.44 Million by 2025 with the CAGR of 4.80% over the forecast period."

Rising prevalence of ophthalmic disorders such as cataract, glaucoma, refractive errors, Age-Related Macular Degeneration (AMD), diabetic retinopathy, and retinal disorders are driving the global Femtosecond Ophthalmic Lasers market.

Get Sample of This Report@ https://brandessenceresearch.com/requestSample/PostId/1035

Scope of Femtosecond Ophthalmic Lasers Market Report-

Femtosecond Ophthalmic Lasers allow accurate treatment of a variety of eye problems with little risk of infection. Many laser procedures are relatively pain free and performed on an outpatient basis. The combination of safety, relative low cost andaccuracymake lasers very useful ophthalmic tools. Additionally applications of lasers consist of the utilization of Argon laser for treatment of glaucoma, retinal detachments, wild hairs on the eyelid, diabetic retinopathy, vein occlusions, retinal holes and rarely In early sorts of the wet sort of age related degeneration. Krypton laser is usually used for a spread of retinal diseases. The use of Femtosecond Ophthalmic Lasers has become quite common place within the surgical care of the many eye disorders and within the case of a cloudy capsule can clear vision and within the case of other disorders can preserve sight.Some Femtosecond Ophthalmic Lasers are also used for photodynamic therapy. For photocoagulation ophthalmologists use, frequency-doubled Nd:YAG lasers, argon, dye, krypton and diode to coagulate abnormal vascular tissue in the retina. Among these, dye and diode lasers are being used in the photodynamic treatment of intraocular tumors.

Femtosecond Ophthalmic Lasers market report is segmented on the basis of product, type, application, end user and by regional & country level. Based upon product, Femtosecond Ophthalmic Lasers market is classified into femtosecond lasers, excimer lasers, Nd:YAGlasers, diode lasers and other lasers. Based upon type, Femtosecond Ophthalmic Lasers market is classified into photodisruption lasers, selective trabeculoplasty laser (SLT) and photocoagulation lasers. Based upon application, Femtosecond Ophthalmic Lasers market is classified into glaucoma, cataract removal, refractive error corrections, diabetic retinopathy, AMD and others. Based upon end user, Femtosecond Ophthalmic Lasers market is classified into hospitals, clinics and ambulatory service center.

The regions covered in this Femtosecond Ophthalmic Lasers market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Femtosecond Ophthalmic Lasers is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Femtosecond Ophthalmic Lasers Companies:

Femtosecond Ophthalmic Lasers market report covers prominent players like,

Carl ZiessMeditec Ag
Novartis AG
Topcon Corporation
Ellex Medical Corporation
Quantel Inc.
Iridex Corporation
Nidek Co., LTD
Lumenis
Abbott Laboratories
Ziemer Ophthalmic Systems.
Lightmed USA
Coherent, Inc.
Ocular Instruments
AsicoLLC.
Deka M.E.L.A. S.r.l.
NoIR Laser Company, LLC.
Others.

Global Femtosecond Ophthalmic Lasers Market Dynamics –

Increasing prevalence of ophthalmic disorders such as cataract, glaucoma, refractive errors, Age-Related Macular Degeneration (AMD), diabetic retinopathy, and retinal disorders driving the growth of market. According to NCBI, Glaucoma, the second leading cause of blindness, affects approximately 64.3 million individuals globally.The prevalence of visual impairment-related diseases is increasing globally, due to change in lifestyle, such as smoking tobacco. Femtosecond Ophthalmic Lasers provide a viable alternative for treatment of eye-related diseases, such as glaucoma, cataract, refractive error, age-related macular degeneration, and diabetic retinopathy. Moreover, increase in geriatric population is also driving the growth of the market. Aging population is commonly affected with various eye disorders. According to WHO, globally, at least 2.2 billion people affected with Blindness and vision impairment Most of them tend to develop cataract and hyperopia. Hence, geriatric population is considered as a lucrative target customer base for the market. However, high cost of ophthalmic laser therapies adoption among the end users and lack of skilled practitioners which are expected to hamper the growth of the global market. Moreover, due to technological advancements Femtosecond Ophthalmic Lasers in healthcare sectors and increasing government initiatives and collaboration with market players for raising awareness regarding the innovative lasers technologies and products is predicted to create wide opportunities for the players operating in the Femtosecond Ophthalmic Lasers marketduring forecast period. According to National Eye Institute, 2.7 million Americans have glaucoma and an estimated 4.3 million will have glaucoma by 2030.

Global Femtosecond Ophthalmic Lasers Market Regional Analysis –

North America is dominating the Femtosecond Ophthalmic Lasers market with the potential rate in terms of revenue for Femtosecond Ophthalmic Lasers due to wide range research and development activities and early adoption of new technologies in the region. Furthermore,presence of key players in Femtosecond Ophthalmic Lasers manufacturing and increased growth in research and developed healthcare organizationand promising government initiatives in implementing Femtosecond Ophthalmic Lasers in ophthalmic disease management and reimbursement will propel the Femtosecond Ophthalmic Lasers market growth during forecast period. In the U.S., more than 120,000 are blind from glaucoma, accounting for 9% to 12% of all cases of blindness.

Europe is projected to be the second largest market in the global Femtosecond Ophthalmic Lasers due to increased ophthalmic diseases surgeries and implementation of high healthcare concerns in the region. Besides, rising geriatric population with ophthalmic disorders improve the market in the region.

The Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period with due to the increase in healthcare expenditure, increasing number of hospitals &laboratories and also increasing patient awareness levels for ophthalmic laser treatment options. However, increasing number of hospitals and ophthalmic clinics in emerging economies such as China, and India are providing immense growth opportunities for the Femtosecond Ophthalmic Lasers market. Latin American countries such as Mexico and Brazil are expected to have considerable potential for driving the market growth due to increasing healthcare expenditure and evolving medical structure.

Key Benefits for Femtosecond Ophthalmic Lasers Market Reports –

Global Market report covers in depth historical and forecast analysis.

Global Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.

Global Market report helps to identify opportunities in market place.

Global Market report covers extensive analysis of emerging trends and competitive landscape.

Femtosecond Ophthalmic Lasers Market Segmentation –

By Product: Femtosecond Lasers, Excimer Lasers, Nd:YAG Lasers, Diode Lasers, Other Lasers

By Type: Photodisruption Lasers, Selective Trabeculoplasty Laser (SLT), Photocoagulation Lasers

By Application: Glaucoma, Cataract Removal, Refractive Error Corrections, Diabetic Retinopathy, AMD, Others

By End User: Hospitals, Clinics, Ambulatory Service Center

Regional & Country Analysis
North America, U.S., Mexico, Canada , Europe, UK, France, Germany, Italy , Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of Middle East and Africa